At the Washington University in St. Louis Board of Trustees meeting May 7, numerous faculty members were appointed or promoted with tenure or granted tenure, with most effective July 1.
Garrett King, a graduate student in the Department of Physics in Arts & Sciences, has been awarded a Stewardship Science Graduate Fellowship by the U.S. Department of Energy National Nuclear Security Administration.
The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial. The study is led by scientists at the School of Medicine and other institutions.
Ramakrishna Kommagani, assistant professor of obstetrics and gynecology at the School of Medicine, received a five-year $1.86 million grant from the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health (NIH) for his research titled “Role of the Gut Microbiota in Endometriosis.”
Researchers at Washington University School of Medicine have discovered that the immune cells stationed in the protective tissue known as the meninges come primarily from the skull. The finding opens up the possibility of developing therapies to target such cells as a way to prevent or treat brain conditions.
An interdisciplinary team at Washington University finds that combining certain data after a patient’s first treatment can predict how a breast cancer tumor is responding to chemotherapy.
The National Institutes of Health (NIH) has awarded Michael Vahey, at the McKelvey School of Engineering, a two-year $433,125 grant for research into virus vulnerability.
Researchers at Washington University School of Medicine and Cornell University have implanted insulin-secreting cells into diabetic mice to normalize their blood sugar.
Washington University investigators now have access to a new research tool that allows them to conduct clinical studies using synthetic patient data. Synthetic data produced by the new tool, called MDClone, accurately mimics real patient data without the privacy concerns.
Olin Business School’s Tony Sardella, along with Paolo De Bona, PMBA ’20, will join the Brookings Institution for a virtual public forum on June 11 to discuss their research on the shortage of critical pharmaceutical drugs in U.S.
